Vimarsana
Biggest News Aggregation in the World

Page 27 - Securities Act News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Securities Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Securities Act Today - Breaking & Trending Today

Immuron Board Changes - Vimarsana News

Immuron Board Changes

MELBOURNE, Australia, May 31, 2024 -- Immuron Limited , an Australian based and globally integrated biopharmaceutical company, advises that Dr Roger Aston has resigned from his position as...

VCI Global : Market Offering Agreement - Form 6-K - Vimarsana News

VCI Global : Market Offering Agreement - Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER ...

Vertiv Issues 2023 Responsible Business Report, Providing Updates on Environmental Impact and Governance Efforts and Introducing 'One Vertiv, One World' Plan - Vimarsana News

Vertiv Issues 2023 Responsible Business Report, Providing Updates on Environmental Impact and Governance Efforts and Introducing 'One Vertiv, One World' Plan

Vertiv , a global provider of critical digital infrastructure and continuity solutions, today released its 2023 Responsible Business Report, which details progress in focus areas, and introduces the...

Turkcell Iletisim Hizmetleri : Announcement Regarding the Application to the Capital Markets Board for a Debt Instrument Issuance in the Domestic Market - Form 6-K - Vimarsana News

Turkcell Iletisim Hizmetleri : Announcement Regarding the Application to the Capital Markets Board for a Debt Instrument Issuance in the Domestic Market - Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE...

Immuron Board Changes - Immuron (NASDAQ:IMRN) - Vimarsana News

Immuron Board Changes - Immuron (NASDAQ:IMRN)

MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Dr Roger Aston has resigned from his